Company intelligence / Profile preview

RJD Medicinal Chemistry and Drug Discovery Consulting LLC

Westfield, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Consulting firm involved in developing small molecule inhibitors like RAGE406R for diabetes complications, showing efficacy in reducing inflammation and improving wound healing in preclinical models.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Consulting

Partnerships

Sprint BioscienceNYUUniversity at Albany

Beyond the preview

Go deeper on RJD Medicinal Chemistry and Drug Discovery Consulting LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RJD Medicinal Chemistry and Drug Discovery Consulting LLC.

Explore the full profile